10 Best Drug Stocks to Buy Now
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for medicines in China.
Bristol Myers Squibb Co (BMY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pzena Investment Management Richard S. Pzena | 13,301,299 | $752,321,471 | -7% | 2.55% |
| 2. | Millennium Management Israel Englander | 8,482,363 | $479,762,451 | +64% | 0.23% |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 7,769,227 | $439,427,479 | +73% | 0.76% |
| 4. | 4,827,400 | $273,037,744 | -33% | 0.04% | |
| 5. | AQR Capital Management Cliff Asness | 4,006,797 | $226,624,420 | +3% | 0.29% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $54.84 | 1,823 | Officer | 63,932 | 2025-02-14 | Filing | |
| $54.68 | 1,830 | Officer | 62,109 | 2024-11-01 | Filing | |
| $49.78 | 2,000 | Officer | 82,672 | 2023-12-05 | Filing | |
| $48.86 | 3,071 | Officer | 79,384 | 2023-11-28 | Filing | |
| $49.81 | 8,500 | Director | 35,500 | 2023-11-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.62 | 700 | Officer | 11,760 | 2024-11-04 | Filing | |
| $61.25 | 17,986 | Officer | 27,868 | 2023-08-24 | Filing | |
| $61.14 | 732 | Officer | 6,584 | 2023-08-03 | Filing | |
| $67.06 | 50,385 | Officer | 47,751 | 2023-05-03 | Filing | |
| $74.65 | 240,000 | Officer, Director | 236,104 | 2023-02-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 189,944,516 | $10,743,261,824 | 0.18% | |
| 2. | 157,606,190 | $8,914,206,113 | 0.18% | |
| 3. | 96,023,212 | $5,431,072,950 | 0.4% | |
| 4. | 95,144,745 | $5,380,908,898 | 0.21% | |
| 5. | 60,300,475 | $3,410,594,868 | 0.62% |
News See All
10 Stocks on Jim Cramer's Radar
Jim Cramer, the host of Mad Money, recently pointed out a significant gap in the American education system, emphasizing that financial literacy is rarely taught in schools, from middle school all the ...
Jim Cramer Discusses These 11 Stocks & President Trump's Sovereign Wealth Fund
In his latest appearance on CNBC's Squawk on the Street, Jim Cramer discussed President Trump's tariffs on Mexico and their impact on the car industry.
Was Jim Cramer Right About These 12 Stocks?
Unlike the cash-rich tech giants that don’t need lower interest rates, small caps benefit tremendously from falling rates.
Bristol-Myers Squibb Company (NYSE:BMY) Q4 2024 Earnings Call Transcript
Operator: Welcome to the Bristol-Myers Squibb Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
Jim Cramer Tells Viewers To Not Trust Billionaires & Discusses These 11 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on the potential impact on Wall Street from President Trump's potential actions against Denmark, Panama, and South Africa.
10 Best Wide Moat Stocks to Invest In
Russell Investments continues to monitor and analyze the potential for policy changes in President Trump's second term in office.
Jim Cramer's Game Plan: 15 Stocks in Focus
Jim Cramer, the host of Mad Money, discussed the upcoming market and corporate activity to look forward to this week, which will be dominated by earnings reports from various companies and an important...
12 Best Long Term Low Risk Stocks to Buy Right Now
As the DeepSeek craze ignites a sell-off in the tech sector, investors are weighing the implications of the downturn in the long term.
Jim Cramer Breaks Silence On DeepSeek AI Sell-Off & Discusses These 12 Stocks
On the day that Wall Street's favorite AI GPU stock bled 17% in the wake of investors panicking about Chinese AI startup DeepSeek's low development costs for AI, Jim Cramer had a lot to say about the ...
Billionaire Hedge Funds
